Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major
- PMID: 8131484
- DOI: 10.1378/chest.103.4.1276
Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major
Abstract
A case of severe cardiac failure due to iron overload in a patient with beta-thalassemia major is reported. The patient was successfully treated with high-dose ambulatory intravenous deferoxamine (desferrioxamine). This type of chelation appears to be a valuable alternative to subcutaneous deferoxamine administration in the presence of severe iron overload.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
